Stay updated on Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Sign up to get notified when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now shown in the page footer, replacing Revision: v3.6.4. This is a minor platform update and does not affect the study history content.
    Difference
    0.0%
    Check dated 2026-08-08T17:06:38.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The record history shows a new revision label, v3.6.4, replacing the previous v3.6.3, reflecting an updated version of the page history.
    Difference
    0.0%
    Check dated 2026-07-25T10:53:29.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The revision label in the page footer updates from v3.6.2 to v3.6.3. This reflects a minor site update without altering study data or page functionality.
    Difference
    0.0%
    Check dated 2026-07-03T23:58:24.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a small site update; the study history information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T01:20:58.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Version history shows a new revision v3.6.0 replacing v3.5.5. A note has been added stating the study is no longer looking for participants.
    Difference
    0.2%
    Check dated 2026-06-12T14:50:30.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a new site release.
    Difference
    0.0%
    Check dated 2026-06-05T09:53:06.000Z thumbnail image

Stay in the know with updates to Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.